Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value ($000): $241,983 (100.0% shares, 0.0% debt)

Holdings (7)

BVS BIOVENTUS 35.0%

Value ($000) $84,677 Shares 12,096,702 Est. Cost $14.24 Unrealized -45.0%

MDXG MIMEDX GROUP, INC. 27.8%

Value ($000) $67,203 Shares 23,415,584 Est. Cost $7.34 Unrealized -51.6%

TELA TELA BIO, INC. 14.5%

Value ($000) $35,023 Shares 4,110,709 Est. Cost $11.82 Unrealized -29.8%

EYPT EYEPOINT PHARMACEUTICALS INC 13.7%

Value ($000) $33,150 Shares 4,190,921 Est. Cost $4.68 Unrealized +98.5%

— REVANCE THERAPEUTICS INC 5.1%

Value ($000) $12,341 Shares 457,085 Est. Cost $31.50 Unrealized —

— VENUS CONCEPT, INC. 3.0%

Value ($000) $7,189 Shares 21,169,457 Est. Cost $2.99 Unrealized —

MNOV MEDICINOVA INC 1.0%

Value ($000) $2,400 Shares 1,105,941 Est. Cost $2.95 Unrealized -21.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BVS	BIOVENTUS	12,096,702	$84,677	35.0%	$14.24	-45.0%	COM CL A	09075A108
MDXG	MIMEDX GROUP, INC.	23,415,584	$67,203	27.8%	$7.34	-51.6%	COM	602496101
TELA	TELA BIO, INC.	4,110,709	$35,023	14.5%	$11.82	-29.8%	COM	872381108
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$33,150	13.7%	$4.68	+98.5%	COM NEW	30233G209
—	REVANCE THERAPEUTICS INC	457,085	$12,341	5.1%	$31.50	—	COM	761330109
—	VENUS CONCEPT, INC.	21,169,457	$7,189	3.0%	$2.99	—	COM	92332W105
MNOV	MEDICINOVA INC	1,105,941	$2,400	1.0%	$2.95	-21.5%	COM NEW	58468P206